The next board meeting for Tango Therapeutics Inc is on 19 May 2026 for the purpose of Tango Therapeutics Inc First Quarter Earnings Results for 2026See details
Tango Therapeutics Inc has a share price target of US$ 26, revenue growth forecast of -91.6%, and profit growth estimate of -105.7% for FY27, based on top 12 analyst calls.